CABP2 and hearing loss disorder: The first preclinical therapy of Cabp2‐associated hearing impairment used AAV2/1 and AAV‐PHP.eB vectors to deliver Cabp2 coding sequence into the cochleae of P5‐7 Cabp2−/− mice [15].